118 related articles for article (PubMed ID: 29858637)
1. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
[TBL] [Abstract][Full Text] [Related]
2. Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.
Hsu CY; Wang CW; Kuo CC; Chen YH; Lan KH; Cheng AL; Kuo SH
Oncotarget; 2017 Jan; 8(5):7921-7934. PubMed ID: 27974702
[TBL] [Abstract][Full Text] [Related]
3. Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.
Nie K; Shi L; Chen Q; Hu X; Jabbour SK; Yue N; Niu T; Sun X
Clin Cancer Res; 2016 Nov; 22(21):5256-5264. PubMed ID: 27185368
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
[TBL] [Abstract][Full Text] [Related]
5. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
[TBL] [Abstract][Full Text] [Related]
6. Combination of Multiple MRI Parameters Related to Signal Intensity and Volume for Predicting Response to Neoadjuvant Chemoradiotherapy by Patients with Locally Advanced Rectal Cancer.
Tan Z; Xie L; Cheng L; Lin Z; Zhang L; Han P; Li X
Curr Med Imaging; 2023 Nov; ():. PubMed ID: 38031786
[TBL] [Abstract][Full Text] [Related]
7. MRI Tumor Regression Grade Combined with T2-Weighted Volumetry May Predict Histopathological Response in Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy-A New Scoring System Proposal.
Jankovic A; Kovac JD; Dakovic M; Mitrovic M; Saponjski D; Milicevic O; Djuric-Stefanovic A; Barisic G
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892047
[TBL] [Abstract][Full Text] [Related]
8. Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapy.
Tey J; Tan JK; Tan KK; Soon YY; Loi HY; Mohamed JSA; Bakulbhai PA; Ang B; Liang TY
Ann Acad Med Singap; 2023 Jun; 52(6):289-295. PubMed ID: 38904510
[TBL] [Abstract][Full Text] [Related]
9. Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.
Stijns RCH; Leijtens J; de Graaf E; Bach SP; Beets G; Bremers AJA; Beets-Tan RGH; de Wilt JHW
Colorectal Dis; 2023 Feb; 25(2):211-221. PubMed ID: 36104011
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
[TBL] [Abstract][Full Text] [Related]
11. MRI-based radiomic score increased mrTRG accuracy in predicting rectal cancer response to neoadjuvant therapy.
Miranda J; Horvat N; Assuncao AN; de M Machado FA; Chakraborty J; Pandini RV; Saraiva S; Nahas CSR; Nahas SC; Nomura CH
Abdom Radiol (NY); 2023 Jun; 48(6):1911-1920. PubMed ID: 37004557
[TBL] [Abstract][Full Text] [Related]
12. Radiomic Features of Primary Rectal Cancers on Baseline T
Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
Kim HY; Cho SH; Jang JK; Kim B; Lee CM; Lim JS; Moon SK; Oh SN; Seo N; Park SH
Korean J Radiol; 2024 Apr; 25(4):351-362. PubMed ID: 38528693
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathological complete response in locally advanced head and neck squamous cell carcinoma treated with neoadjuvant chemo-immunotherapy using volumetric multisequence MRI histogram analysis.
Liu H; Zhu C; Wang X; Chen X; Li Z; Xian J
Neuroradiology; 2024 Jun; 66(6):919-929. PubMed ID: 38503986
[TBL] [Abstract][Full Text] [Related]
15. The value of multimodality MR in T staging evaluation after neoadjuvant therapy for rectal cancer.
Liu B; Sun C; Zhao X; Liu L; Liu S; Ma H
Technol Health Care; 2024; 32(2):615-627. PubMed ID: 37393447
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
Pikūnienė I; Strakšytė V; Basevičius A; Žilinskas J; Ambrazienė R; Jančiauskienė R; Saladžinskas Ž
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138297
[No Abstract] [Full Text] [Related]
17. Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer.
Bulens P; Couwenberg A; Haustermans K; Debucquoy A; Vandecaveye V; Philippens M; Zhou M; Gevaert O; Intven M
Radiother Oncol; 2018 Mar; 126(3):437-442. PubMed ID: 29395287
[TBL] [Abstract][Full Text] [Related]
18. Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis.
He J; Wang SX; Liu P
Br J Radiol; 2024 Jun; 97(1159):1243-1254. PubMed ID: 38730550
[TBL] [Abstract][Full Text] [Related]
19. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Rampazzo E; Del Bianco P; Bertorelle R; Boso C; Perin A; Spiro G; Bergamo F; Belluco C; Buonadonna A; Palazzari E; Lonardi S; De Paoli A; Pucciarelli S; De Rossi A
Br J Cancer; 2018 Mar; 118(6):878-886. PubMed ID: 29449673
[TBL] [Abstract][Full Text] [Related]
20. Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches.
Kaval G; Dagoglu Kartal MG; Azamat S; Cingoz E; Ertas G; Karaman S; Kurtuldu B; Keskin M; Berker N; Karabulut S; Oral EN; Dagoglu Sakin N
Pathol Oncol Res; 2024; 30():1611744. PubMed ID: 38694706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
